Back
35· Cooling
Markets1h 47m ago
Johnson & Johnson beat Wall Street estimates for second-quarter sales and profit.
Archive Window: 7 Days Left
Global
Who
Johnson & Johnson
What
Johnson & Johnson beat Wall Street estimates for second-quarter sales and profit.
When
Wed, 15 Jul 2026 10:23:09 GMT · 1h 47m ago
Where
Global ·
Why
Strong growth from immunology drug Tremfya and cancer blockbuster Darzalex offset erosion from older products and a drop in sales for heart pumps.
The Frontline Impact
How this affects you
Johnson & Johnson's Q2 financial performance exceeded market expectations, driven by key pharmaceutical products. This indicates continued strength in its medicines division despite challenges in other areas.
Story chain
1 event in this threadNo related history yet - this is the origin event.